Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Neurodegenerative Disease Management, 2026

Plasma proteomic trajectories before the onset of neurodegenerative diseases

Zhang Z., Fan R., Jing S. et al.

Scientific Reports, 2026

Sex-biased plasma inflammatory protein profile in obesity

Halland H., Vitorino R., Gerdts E. et al.

npj Science of Food, 2026

Adherence to the EAT-Lancet Diet and Risk of Sepsis: A Prospective Cohort Study from the UK Biobank

Nan W., Huang Q., He B. et al.

Journal of Inflammation Research, 2026

Identification of a Four-Biomarker Panel for the Diagnosis of Tuberculous Pleural Effusion Using Olink Proteomics

Xing X., Guo C., Zhao G. et al.

Molecular Brain, 2026

Neuro-immune interactions underlying autoimmune diseases: insights from brain imaging data

Gu J., Xing Z., Wang J. et al.

Molecular Biomedicine, 2026

Inflammatory protein profiling in immune cells identifies molecular signatures for enhanced diagnostic precision in psoriatic arthritis

Martín-Salazar J., Arias-de la Rosa I., López-Montilla M. et al.

Journal of Diabetes and its Complications, 2026

Circulating proteomic markers are associated with measures of small and large fiber neuropathy and symptoms in type 2 diabetes

Ponirakis G., Al-Janahi I., Elgassim E. et al.

Nature, 2026

Thymic health consequences in adults

Bernatz S., Prudente V., Pai S. et al.

Nature, 2026

Thymic health and immunotherapy outcomes in patients with cancer

Bernatz S., Prudente V., Pai S. et al.

Clinical Chemistry, 2026

Tumor-Derived HAVCR1 As a Reliable Fluid Biomarker for the Diagnosis of CNS Lymphoma

Li S., Cao J., Ren J. et al.

iScience, 2026

Plasma proteomic profiling with machine learning identifies immunometabolic perturbations associated with smoking and smoking cessation

Ma J., Liu Y., Xu H. et al.

General Psychiatry, 2026

Dementia risk prediction in individuals with prediabetes or diabetes: A novel multi‐protein score with biological pathway analysis

Zhang Y., Huang Y., Xue J. et al.

Helicobacter, 2026

Helicobacter pylori , Inflammation, and Long‐Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort Study

Sundqvist M., Wärme J., Hjort M. et al.

Anaesthesia, 2026

Labour epidural analgesia and early childhood behavioural outcomes: the moderating role of maternal mental health and pro‐inflammatory cytokines

Asif S., Tu H., White R. et al.

Acta Pharmaceutica Sinica B, 2026

Derivatization-enhanced thiol redox atlas reveals ENO1–SLC7A11 axis as Ferroptosis protector in myocardial injury

Ma C., Lin M., Qiao Z. et al.

Journal of Neuroinflammation, 2026

Microglial NCAM1 attenuates ischemic brain injury by inhibiting NF-κB-driven neuroinflammation through IκBα stabilization

Yu Z., Yu L., Lu W. et al.

Thoracic Cancer, 2026

Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR ‐ TKI Resistance in Non‐Small Cell Lung Cancer

Park M., Lim J., Park N. et al.

Pediatric Critical Care Medicine, 2026

Arterial Catheter-Associated Proximal Ischemic Injury in Critically Ill Children: Evidence of Endothelial Dysfunction and Immune Dysregulation

Demopoulos A., Weber M., Liu H. et al.

Communications Medicine, 2026

Proteomics signature of moderate-to-vigorous physical activity and risk of multimorbidity of cancer and cardiometabolic diseases

Stein M., Baurecht H., Bohmann P. et al.

Arthritis Research & Therapy, 2026

Identification of candidate biomarkers for diagnosis, disease activity, and relapse prediction in IgG4-related disease

Hao Q., Lian D., Zhou M. et al.

4555 publications